Laurus Labs (BOM:540222) 3-Year Revenue Growth Rate : 2.00% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs 3-Year Revenue Growth Rate?

Laurus Labs's Revenue per Share for the three months ended in Mar. 2024 was ₹26.55.

During the past 12 months, Laurus Labs's average Revenue per Share Growth Rate was -16.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 2.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 19.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 15.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Laurus Labs was 32.70% per year. The lowest was 2.00% per year. And the median was 10.55% per year.

Competitive Comparison of Laurus Labs's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laurus Labs's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Laurus Labs's 3-Year Revenue Growth Rate falls into.

Laurus Labs 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Laurus Labs (BOM:540222) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Laurus Labs 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Laurus Labs's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Laurus Labs (BOM:540222) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

LAURUSLABS:India

Address

Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034

Website

https://www.lauruslabs.com

Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs (BOM:540222) Headlines

No Headlines